Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma-Reference-Cited by-同舟云学术

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma

Published:2021-01 Issue: Volume:200 Page:106348
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Pierscianek Daniela^ORCID,Ahmadipour Yahya,Michel Anna,Rauschenbach Laurèl^ORCID,Darkwah Oppong Marvin^ORCID,Deuschl Cornelius,Kebir Sied,Wrede Karsten H.,Glas Martin,Stuschke Martin,Sure Ulrich,Jabbarli Ramazan

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference26 articles.

1. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice;Walker;J Neurooncol.,2013

2. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome;Kozak;Neuro Oncol.,2009

3. Genetic profile of gliosarcomas;Reis;Am J Pathol.,2000

4. Radiotherapy plus concomitant temozolomide in primary gliosarcoma;Adeberg;J Neurooncol.,2016

5. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma;Oh;Brain Pathol.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics;Journal of Clinical Medicine;2023-12-22

2. Clinicopathological and Neuroimaging Features of Primary Gliosarcoma: A Case Series and Review of Literature;World Neurosurgery;2023-10

3. Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature;Frontiers in Oncology;2023-01-31

4. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study;Computational and Mathematical Methods in Medicine;2023-01-30

5. Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients;Journal of Neuro-Oncology;2022-04-26